Gunnar Erikssen1, Knut Liestøl2, Egil Seem2, Sigurd Birkeland2, Kjell Johan Saatvedt2, Tom Nilsen Hoel2, Gaute Døhlen2, Helge Skulstad2, Jan Ludvig Svennevig2, Erik Thaulow2, Harald Lauritz Lindberg2. 1. From the Department of Cardiology, Oslo University Hospital, Rikshospitalet, Norway (G.E., H.S.); Department of Informatics, University of Oslo, Norway (K.L.); Department of Thoracic Surgery, Oslo University Hospital, Rikshospitalet, Norway (E.S., S.B., K.J.S., T.N.H., J.L.S., H.L.L.); and Department of Pediatric Cardiology, Oslo University Hospital, Rikshospitalet, Norway (G.D., E.T.). gunnar.erikssen@yahoo.com. 2. From the Department of Cardiology, Oslo University Hospital, Rikshospitalet, Norway (G.E., H.S.); Department of Informatics, University of Oslo, Norway (K.L.); Department of Thoracic Surgery, Oslo University Hospital, Rikshospitalet, Norway (E.S., S.B., K.J.S., T.N.H., J.L.S., H.L.L.); and Department of Pediatric Cardiology, Oslo University Hospital, Rikshospitalet, Norway (G.D., E.T.).
Abstract
BACKGROUND: This article presents an update of the results achieved by modern surgery in congenital heart defects (CHDs) over the past 40 years regarding survival and the need for reoperations, especially focusing on the results from the past 2 decades. METHODS AND RESULTS: From 1971 to 2011, all 7038 patients <16 years of age undergoing surgical treatment for CHD at Rikshospitalet (Oslo, Norway) were enrolled prospectively. CHD diagnosis, date, and type of all operations were recorded, as was all-cause mortality until December 31, 2012. CHDs were classified as simple (3751/7038=53.2%), complex (2918/7038=41.5%), or miscellaneous (369/7037=5.2%). Parallel to a marked, sequential increase in operations for complex defects, median age at first operation decreased from 1.6 years in 1971 to 1979 to 0.19 years in 2000 to 2011. In total, 1033 died before January 1, 2013. Cumulative survival until 16 years of age in complex CHD operated on in 1971 to 1989 versus 1990 to 2011 was 62.4% versus 86.9% (P<0.0001). In the comparison of patients operated on in 2000 to 2004 versus 2005 to 2011, 1-year survival was 90.7% versus 96.5% (P=0.003), and 5-year cumulative survival was 88.8% versus 95.0% (P=0.0003). In simple versus complex defects, 434 (11.6%) versus 985 (33.8%) patients needed at least 1 reoperation before 16 years of age. In complex defects, 5-year cumulative freedom of reoperation among patients operated on in 1990 to 1999 versus 2000 to 2011 was 66% versus 73% (P=0.0001). CONCLUSIONS: Highly significant, sequential improvements in survival and reductions in reoperations after CHD surgery were seen. A future challenge is to find methods to reduce the need for reoperations and further reduce long-term mortality.
BACKGROUND: This article presents an update of the results achieved by modern surgery in congenital heart defects (CHDs) over the past 40 years regarding survival and the need for reoperations, especially focusing on the results from the past 2 decades. METHODS AND RESULTS: From 1971 to 2011, all 7038 patients <16 years of age undergoing surgical treatment for CHD at Rikshospitalet (Oslo, Norway) were enrolled prospectively. CHD diagnosis, date, and type of all operations were recorded, as was all-cause mortality until December 31, 2012. CHDs were classified as simple (3751/7038=53.2%), complex (2918/7038=41.5%), or miscellaneous (369/7037=5.2%). Parallel to a marked, sequential increase in operations for complex defects, median age at first operation decreased from 1.6 years in 1971 to 1979 to 0.19 years in 2000 to 2011. In total, 1033 died before January 1, 2013. Cumulative survival until 16 years of age in complex CHD operated on in 1971 to 1989 versus 1990 to 2011 was 62.4% versus 86.9% (P<0.0001). In the comparison of patients operated on in 2000 to 2004 versus 2005 to 2011, 1-year survival was 90.7% versus 96.5% (P=0.003), and 5-year cumulative survival was 88.8% versus 95.0% (P=0.0003). In simple versus complex defects, 434 (11.6%) versus 985 (33.8%) patients needed at least 1 reoperation before 16 years of age. In complex defects, 5-year cumulative freedom of reoperation among patients operated on in 1990 to 1999 versus 2000 to 2011 was 66% versus 73% (P=0.0001). CONCLUSIONS: Highly significant, sequential improvements in survival and reductions in reoperations after CHD surgery were seen. A future challenge is to find methods to reduce the need for reoperations and further reduce long-term mortality.
Authors: Logan G Spector; Jeremiah S Menk; Jessica H Knight; Courtney McCracken; Amanda S Thomas; Jeffrey M Vinocur; Matthew E Oster; James D St Louis; James H Moller; Lazaros Kochilas Journal: J Am Coll Cardiol Date: 2018-05-29 Impact factor: 24.094
Authors: Rhoia Neidenbach; Koichiro Niwa; Oeztekin Oto; Erwin Oechslin; Jamil Aboulhosn; David Celermajer; Joerg Schelling; Lars Pieper; Linda Sanftenberg; Renate Oberhoffer; Fokko de Haan; Michael Weyand; Stephan Achenbach; Christian Schlensak; Dirk Lossnitzer; Nicole Nagdyman; Yskert von Kodolitsch; Hans-Carlo Kallfelz; David Pittrow; Ulrike M M Bauer; Peter Ewert; Thomas Meinertz; Harald Kaemmerer Journal: Cardiovasc Diagn Ther Date: 2018-12
Authors: Patrick Y Jay; Ehiole Akhirome; Rachel A Magnan; M Rebecca Zhang; Lillian Kang; Yidan Qin; Nelson Ugwu; Suk Dev Regmi; Julie M Nogee; James M Cheverud Journal: Mol Cell Endocrinol Date: 2016-08-20 Impact factor: 4.102
Authors: Jason L Williams; Rachel D Torok; Alfred D'Ottavio; Tracy Spears; Karen Chiswell; Nina E Forestieri; Charlie J Sang; Joseph A Paolillo; Michael J Walsh; Timothy M Hoffman; Alex R Kemper; Jennifer S Li Journal: Pediatr Cardiol Date: 2021-04-22 Impact factor: 1.655
Authors: T Baehner; O Boehm; M Kliemann; I Heinze; J Breuer; A Hoeft; G Baumgarten; P Knuefermann Journal: Anaesthesist Date: 2015-06 Impact factor: 1.041
Authors: Francisco José Ferrer-Sargues; Esteban Peiró-Molina; Maria Àngels Cebrià I Iranzo; José Ignacio Carrasco Moreno; Ana Cano-Sánchez; María Isabel Vázquez-Arce; Beatriz Insa Albert; Pablo Salvador-Coloma Journal: Int J Environ Res Public Health Date: 2021-05-30 Impact factor: 3.390